跳至主要内容
临床试验/NCT04766749
NCT04766749已完成不适用

Remote Ischemic Preconditioning on the Prognosis of Patients With Elective PCI Using Drug-coated Balloon

Henan Institute of Cardiovascular Epidemiology1 个研究点 分布在 1 个国家目标入组 430 人开始时间: 2021年2月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
430
试验地点
1
主要终点
TLF

研究概览

简要总结

Drug-coated balloon is being used more and more widely for the advantage of intervention without implantation.

But the balloon needs to be released long enough to be effective. Prolonged balloon dilation resulting in the cessation of blood flow in the distal vessels, especially large vessels, may result in severe ischemia in the patient.

RIPC can enhance patients' tolerance to ischemic events, so we believe that RIPC application before the use of drug balloon for PCI can improve patients' ischemic symptoms, thus increasing the release time of drug balloon and improving the effect.

详细描述

Some patients receiving PCI cannot tolerate the symptoms of myocardial ischemia caused by the release of the drug balloon for a long time and even lead to the occurrence of adverse events.RIPC was found to improve tolerance to myocardial ischemia in patients.

At the same time, it can open collateral circulation and improve the tolerance of myocardial ischemia in patients.Therefore, this study designed a parallel control group. The experimental group was treated with RIPC before PCI, while the control group was not treated before PCI.

The operator does not know whether the patient has undergone RIPC or not, and the operator decides the time of drug balloon release according to the symptoms of the patient during the operation.Angiography was performed at 6 months, and QCA was used to determine late lumen loss at 1 year.The 1-year incidence of target lesion failure events was assessed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

盲法说明

Before the operation, the nurse chooses the patient to perform RIPC or not according to a predefined random method, and then the operation is performed by the operator.

The operator did not know if the patient had undergone RIPC. Outcome evaluators also did not know the grouping of patients

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diameter stenosis>=50% by visual estimation intend to undergo drug-coated balloon implantation
  • Target vessel diameter> 2.5mm

排除标准

  • Chronic Total Obstructive lesion
  • Diagnose patients with acute myocardial infarction <24 hours
  • Can't tolerate or not suitable for RIPC
  • Severe hepatic and renal insufficiency
  • Expected survival <1 year
  • Severe calcification needing rotational atherectomy
  • Intolerable to dual antiplatelet therapy

结局指标

主要结局

TLF

时间窗: 12 months

TLF, a composite of cardiac death, target vessel-related myocardial infarction (MI; not clearly attributed to a nontarget vessel and excluding periprocedural MI), or clinically indicated target lesion revascularization (TLR)

次要结局

  • DCB expansion time(less than 120 seconds (On the 1 day of PCI))
  • Late lumen loss of target vessel(mm)(6 months)

研究者

发起方
Henan Institute of Cardiovascular Epidemiology
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验